Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer

被引：0
作者：
G. Sommerhäuser
A. Kurreck
S. Stintzing
V. Heinemann
L. Fischer von Weikersthal
T. Dechow
F. Kaiser
M. Karthaus
I. Schwaner
M. Fuchs
A. König
C. Roderburg
I. Hoyer
M. Quante
A. Kiani
S. Fruehauf
L. Müller
A. Reinacher-Schick
T. J. Ettrich
A. Stahler
D. P. Modest
机构：
[1] Charité – Universitätsmedizin Berlin,Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM)
[2] corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin,Department of Hematology/Oncology
[3] German Cancer Consortium (DKTK),Department of Hematology and Oncology
[4] DKFZ,Department of Gastroenterology, Hepatology, and Gastrointestinal Oncology
[5] LMU Klinikum,Department of Gastroenterology and Gastrointestinal Oncology Goettingen
[6] University of Munich,Department of Gastroenterology, Hepatology, and Infectiology
[7] Comprehensive Cancer Center Munich,Department of Gastroenterology, Hepatology, Endocrinology, and Infectiology
[8] Gesundheitszentrum St. Marien,Department of Medicine IV
[9] Oncological Practice,Department of Hematology, Oncology, and Palliative Care
[10] Oncological Practice,Department of Hematology, Oncology and Palliative Care
[11] Klinikum Neuperlach/ Klinikum Harlaching,Department of Internal Medicine
[12] Oncological Practice Kurfuerstendamm,undefined
[13] München Klinik Bogenhausen,undefined
[14] University Medical Center Goettingen,undefined
[15] University Medical Center Duesseldorf,undefined
[16] Albert-Ludwigs-Universität Freiburg,undefined
[17] Klinikum Bayreuth GmbH,undefined
[18] Klinik Dr. Hancken GmbH,undefined
[19] Onkologie UnterEms,undefined
[20] Ruhr-University Bochum,undefined
[21] University Hospital Ulm,undefined
来源：
BMC Cancer | / 22卷
关键词：
Metastatic Colorectal Cancer; Trifluridine/tipiracil; Bevacizumab; Panitumumab; First-line treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 203 条
[31]  
Lang I(undefined)undefined undefined undefined undefined-undefined
[32]  
Marcuello E(undefined)undefined undefined undefined undefined-undefined
[33]  
Lorusso V(undefined)undefined undefined undefined undefined-undefined
[34]  
Ocvirk J(undefined)undefined undefined undefined undefined-undefined
[35]  
Shin DB(undefined)undefined undefined undefined undefined-undefined
[36]  
Jonker D(undefined)undefined undefined undefined undefined-undefined
[37]  
Osborne S(undefined)undefined undefined undefined undefined-undefined
[38]  
Andre N(undefined)undefined undefined undefined undefined-undefined
[39]  
Waterkamp D(undefined)undefined undefined undefined undefined-undefined
[40]  
Kabbinavar FF(undefined)undefined undefined undefined undefined-undefined
12345678910